Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
Optibrium Receives Further Investment From Kester Capital
Optibrium™, a developer of software for drug discovery, today announced it has secured further investment […]
MicroTransponder Raises $53M, Appoints New CEO
MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment […]
3Z Closes $2 Million Funding for Preclinical Development of Novel ADHD and Insomnia Therapeutics Identified by 3Z´s Zebrafish Drug Discovery Platform
3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round […]
Therorna Completes Series A Financing to Accelerate Pipeline Development and Clinical Transformation of circRNA-based Platform
Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) […]
Aidoc Raises $110M to Address the Increasing Challenges Facing Health Systems by Using Artificial Intelligence
Aidoc, the leading provider of healthcare AI solutions, announced today a $110 million Series D round investment, […]
Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer
Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate […]
H1 Secures an Extension on Its Series C to Further Its Mission of Creating a Healthier Future Through the Use of Connected and Accessible Healthcare Data
H1, the connecting force for global healthcare professional, clinical, science, and research information, announced today […]
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more